Shareholder structure and regional distribution (September 2007)

Susanne Klatten holds 50.1% of the issued capital indirectly via SKion GmbH. Our majority stakeholder’s share in the company remains the same following the sale of the Pharmaceuticals business. 49.9% of the nominal capital, which is divided into 140.4 million no-par value shares, is in free float, with ALTANA still owning 4.4 million shares (3.1% of the nominal capital). As of September 2007, the remaining 46.8% of ALTANA shares were owned by more than 250 identified institutional investors and an unrecorded number of additional, unidentified institutional investors and private shareholders.

Most of the institutional investors whose shareholdings are recorded came from Great Britain, owning just under 8% of the shares outstanding and 15% of the free float. They were followed by institutional investors in the U.S. and in Germany. Shareholders in each of these countries held 7% of all the shares and 14% of the free float. The institutional investors from other European countries together possessed another 8% of all shares and 15% of the free float. The ten largest recorded institutional investors together held nearly 15% of the nominal capital.